D-1289-2020 Class III Terminated

Recalled by AVKARE Inc. — Pulaski, TN

FDA drug recall D-1289-2020 was initiated by AVKARE Inc. on May 28, 2020 and is designated Class III. Reason for recall: Presence of Foreign Substance consistent with granules from desiccant packs used during storage The recall status is terminated (terminated Oct 22, 2021). Affected quantity: 4124 bottles.

Recall details

Product Type
Drugs
Report Date
Jun 10, 2020
Initiation Date
May 28, 2020
Termination Date
Oct 22, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4124 bottles

Product description

Lamotrigine Tablets, USP, 150 mg, Rx Only, a) 60 count Bottle, NDC 42291-368-60, b) 500 count Bottle, NDC 42291-368-50, Manufactured for: AvKARE, Inc. Pulaski, TN 38478.

Reason for recall

Presence of Foreign Substance consistent with granules from desiccant packs used during storage

Distribution pattern

Nationwide in the U.S.

Code information

Lot #: a) 25634, b) 25633; Exp. 09/30/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1289-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1289-2020. Report a data issue: hello@regdatalab.com.